Industry
Medical - Devices
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Loading...
Open
0.51
Mkt cap
34M
Volume
274K
High
0.51
P/E Ratio
-0.29
52-wk high
2.36
Low
0.46
Div yield
N/A
52-wk low
0.30
Portfolio Pulse from Nabaparna Bhattacharya
September 27, 2024 | 11:37 am
Portfolio Pulse from Nabaparna Bhattacharya
September 27, 2024 | 11:34 am
Portfolio Pulse from Benzinga Newsdesk
August 16, 2024 | 4:04 pm
Portfolio Pulse from Benzinga Newsdesk
August 16, 2024 | 12:47 pm
Portfolio Pulse from Benzinga Newsdesk
August 07, 2024 | 11:33 am
Portfolio Pulse from Benzinga Newsdesk
August 06, 2024 | 9:35 pm
Portfolio Pulse from Benzinga Newsdesk
August 06, 2024 | 9:19 pm
Portfolio Pulse from Benzinga Newsdesk
August 06, 2024 | 8:43 pm
Portfolio Pulse from Benzinga Newsdesk
July 31, 2024 | 9:05 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.